Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Ebert, Judith Hall, J. Barney, T. Uhrich, Maelynn Colinco (2000)
The Effects of Increasing Plasma Concentrations of Dexmedetomidine in HumansAnesthesiology, 93
A. Mukhtar, Eman Obayah, Amira Hassona (2006)
The Use of Dexmedetomidine in Pediatric Cardiac SurgeryAnesthesia & Analgesia, 103
F. Su, S. Nicolson, M. Gastonguay, J. Barrett, P. Adamson, D. Kang, R. Godinez, A. Zuppa (2010)
Population Pharmacokinetics of Dexmedetomidine in Infants After Open Heart SurgeryAnesthesia & Analgesia, 110
T. Tateishi, H. Nakura, M. Asoh, Minoru Watanabe, Masami Tanaka, T. Kumai, S. Takashima, S. Imaoka, Y. Funae, Y. Yabusaki, T. Kamataki, Shinichi Kobayashi (1997)
A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy.Life sciences, 61 26
M. Bergstrand, A. Hooker, J. Wallin, M. Karlsson (2011)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects ModelsThe AAPS Journal, 13
Hoai‐Thu Thai, F. Mentré, N. Holford, C. Veyrat‐Follet, E. Comets (2014)
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokineticsJournal of Pharmacokinetics and Pharmacodynamics, 41
U. Wählby, E. Jonsson, M. Karlsson (2002)
Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysisAAPS PharmSci, 4
D. Mould, R. Upton (2013)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling MethodsCPT: Pharmacometrics & Systems Pharmacology, 2
Amanda Potts, B. Anderson, G. Warman, J. Lerman, S. Díaz, Sanna Vilo (2009)
Dexmedetomidine pharmacokinetics in pediatric intensive care – a pooled analysisPediatric Anesthesia, 19
Jiheum Park, D. Shin, Saram Lee, Y. Cho, S. Jheon, J. Lee, Hee Kim (2017)
Investigation of Key Circuit Constituents Affecting Drug Sequestration During Extracorporeal Membrane Oxygenation TreatmentASAIO Journal, 63
F. Su, M. Gastonguay, S. Nicolson, M. Diliberto, Alanna Ocampo-Pelland, A. Zuppa (2016)
Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart SurgeryAnesthesia & Analgesia, 122
R. Ben-Abraham,, A. Weinbroum, D. Lotan, O. Dagan, Rivka Schreriber-Scheffer, D. Mishali, R. Harel, T. Vishne, Z. Barzilay, G. Paret (2002)
Interleukin‐8 secretion following cardiopulmonary bypass in children as a marker of early postoperative morbidityPediatric Anesthesia, 12
G. Hill (1996)
The Inflammatory Response to Cardiopulmonary BypassInternational Anesthesiology Clinics, 34
D. Sinclair, P. Haslam, G. Quinlan, J. Pepper, T. Evans (1995)
The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability.Chest, 108 3
E. Wildschut, M. Ahsman, K. Allegaert, R. Mathôt, D. Tibboel (2010)
Determinants of drug absorption in different ECMO circuitsIntensive Care Medicine, 36
R. Keizer, R. Jansen, H. Rosing, B. Thijssen, J. Beijnen, J. Schellens, A. Huitema (2015)
Incorporation of concentration data below the limit of quantification in population pharmacokinetic analysesPharmacology Research & Perspectives, 3
F. Su, S. Nicolson, A. Zuppa (2013)
A Dose-Response Study of Dexmedetomidine Administered as the Primary Sedative in Infants Following Open Heart SurgeryPediatric Critical Care Medicine, 14
E. Ista, M. Dijk, D. Tibboel, M. Hoog (2005)
Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT “behavior” scale*Pediatric Critical Care Medicine, 6
Xiaopeng Zhang, Ulrich Schmidt, J. Wain, L. Bigatello (2010)
Bradycardia leading to asystole during dexmedetomidine infusion in an 18 year-old double-lung transplant recipient.Journal of clinical anesthesia, 22 1
L. Schwartz, Mark Twite, B. Gulack, K. Hill, Sunghee Kim, D. Vener (2016)
The Perioperative Use of Dexmedetomidine in Pediatric Patients with Congenital Heart Disease: An Analysis from the Congenital Cardiac Anesthesia Society-Society of Thoracic Surgeons Congenital Heart Disease DatabaseAnesthesia & Analgesia, 123
D. Wagner, D. Pasko, Kristine Phillips, J. Waldvogel, G. Annich (2013)
In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenationPerfusion, 28
N. Fukuoka, M. Aibiki, T. Tsukamoto, K. Seki, S. Morita (2004)
Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia.Resuscitation, 60 2
R. Mathie, S. Ohri, J. Batten, A. Peters, B. Keogh (1997)
Hepatic blood flow during cardiopulmonary bypass operations: the effect of temperature and pulsatility.The Journal of thoracic and cardiovascular surgery, 114 2
T. Iirola, H. Ihmsen, R. Laitio, E. Kentala, R. Aantaa, J. Kurvinen, M. Scheinin, H. Schwilden, J. Schüttler, K. Olkkola (2012)
Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.British journal of anaesthesia, 108 3
D. Morales, Kathleen Carberry, J. Heinle, E. Mckenzie, C. Fraser, L. Diaz (2008)
Extubation in the operating room after Fontan's procedure: effect on practice and outcomes.The Annals of thoracic surgery, 86 2
T. Kugelman, Aaron Lerner (2006)
of Medicine
J. Klamt, W. Vicente, L. Garcia, César Ferreira (2010)
Hemodynamic effects of the combination of dexmedetomidine-fentanyl versus midazolam-fentanyl in children undergoing cardiac surgery with cardiopulmonary bypass.Revista brasileira de anestesiologia, 60 4
Steven, Craig, J. McClain, Daniell, B. Hill, Robert Blouint (1994)
Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.The Journal of clinical investigation, 94 6
C. Chrysostomou, S. Filippo, A. Manrique, C. Schmitt, R. Orr, A. Casta, Erin Suchoza, J. Janosky, P. Davis, R. Munoz (2006)
Use of dexmedetomidine in children after cardiac and thoracic surgery*Pediatric Critical Care Medicine, 7
J. Berkenbosch, J. Tobias (2003)
Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxinPediatric Critical Care Medicine, 4
C. Chrysostomou, J. Toledo, Tracy Avolio, M. Motoa, D. Berry, V. Morell, R. Orr, R. Munoz (2009)
Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery?Pediatric Critical Care Medicine, 10
J. Levy, Kenichi Tanaka (2003)
Inflammatory response to cardiopulmonary bypass.The Annals of thoracic surgery, 75 2
S. Beal (2001)
Ways to Fit a PK Model with Some Data Below the Quantification LimitJournal of Pharmacokinetics and Pharmacodynamics, 28
M. Laughon, D. Benjamin, E. Capparelli, G. Kearns, Katherine Berezny, I. Paul, K. Wade, J. Barrett, P. Smith, M. Cohen-Wolkowiez (2011)
Innovative clinical trial design for pediatric therapeuticsExpert Review of Clinical Pharmacology, 4
(2018)
Clinical Pharmacology Review: NDA 21–038 S21 S222013
B. Achuff, S. Nicolson, O. Elci, A. Zuppa (2015)
Intraoperative Dexmedetomidine Reduces Postoperative Mechanical Ventilation in Infants After Open Heart SurgeryPediatric Critical Care Medicine, 16
A. Mori, Kazuo Watanabe, M. Onoe, S. Watarida, Y. Nakamura, T. Magara, Ryoko Tabata, Y. Okada (1988)
Regional blood flow in the liver, pancreas and kidney during pulsatile and nonpulsatile perfusion under profound hypothermia.Japanese circulation journal, 52 3
M. Coughtrie, Brian Burchell, J. Leakey, Robert Hume (1988)
The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.Molecular pharmacology, 34 6
M. Buck (2003)
Pharmacokinetic Changes During Extracorporeal Membrane OxygenationClinical Pharmacokinetics, 42
Yaning Wang, P. Jadhav, Mallika Lala, J. Gobburu (2012)
Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic StudiesThe Journal of Clinical Pharmacology, 52
E. Manolis, T. Osman, R. Herold, F. Koenig, P. Tomasi, S. Vamvakas, A. Raymond (2011)
Role of modeling and simulation in pediatric investigation plansPediatric Anesthesia, 21
J. Utley, C. Wachtel, R. Cain, E. Spaw, J. Collins, D. Stephens (1981)
Effects of hypothermia, hemodilution, and pump oxygenation on organ water content, blood flow and oxygen delivery, and renal function.The Annals of thoracic surgery, 31 2
M. Field, R. Behrman (2004)
Committee on Clinical Research Involving Children
C. Chrysostomou, J. Sanchez-de-Toledo, P. Wearden, E. Jooste, S. Lichtenstein, P. Callahan, Tunga, Suresh, Elizabeth O'Malley, D. Shiderly, J. Haney, Masahiro Yoshida, R. Orr, R. Munoz, V. Morell (2012)
Perioperative Use of Dexmedetomidine is Associated with Decreased Incidence of Ventricular and Supraventricular Tachyarrhythmias after Congenital Cardiac Surgery
S. Dutta, R. Lal, M. Karol, Theodore Cohen, Thomas Ebert (2000)
Influence of cardiac output on dexmedetomidine pharmacokinetics.Journal of pharmaceutical sciences, 89 4
G. Heinz, C. Kratochwill, P. Buxbaum, G. Kreiner, Günther Laufer, H. Gössinger, A. Laczkovics (1992)
Long‐Term Intrinsic Pacemaker Function in Patients Paced for Sinus Node Deficiency After Cardiac TransplantationPacing and Clinical Electrophysiology, 15
Susan Díaz, Alexander Rodarte, Jennifer Foley, Edmund Capparelli (2007)
Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: Preliminary study*Pediatric Critical Care Medicine, 8
Amanda Potts, G. Warman, B. Anderson (2008)
Dexmedetomidine disposition in children: a population analysisPediatric Anesthesia, 18
R. Greenberg, Huali Wu, M. Laughon, E. Capparelli, Stevie Rowe, K. Zimmerman, P. Smith, M. Cohen-Wolkowiez (2017)
Population Pharmacokinetics of Dexmedetomidine in InfantsThe Journal of Clinical Pharmacology, 57
L. Piper, Brian Smith, Christoph Hornik, I. Cheifetz, J. Barrett, G. Moorthy, W. Hope, K. Wade, M. Cohen-Wolkowiez, D. Benjamin (2011)
Fluconazole Loading Dose Pharmacokinetics and Safety in InfantsThe Pediatric Infectious Disease Journal, 30
Guy Pétroz, N. Sikich, M. James, H. Dyk, S. Shafer, M. Schily, J. Lerman (2006)
A Phase I, Two-center Study of the Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in ChildrenAnesthesiology, 105
BACKGROUND: Dexmedetomidine is increasingly used off-label in infants and children with cardiac disease during cardiopulmonary bypass (CPB) and in the postoperative period. Despite its frequent use, optimal dosing of dexmedetomidine in the setting of CPB has not been identified but is expected to differ from dosing in those not supported with CPB. This study had the following aims: (1) characterize the effect of CPB on dexmedetomidine clearance (CL) and volume of distribution (V) in infants and young children; (2) characterize tolerance and sedation in patients receiving dexmedetomidine; and (3) identify preliminary dosing recommendations for infants and children undergoing CPB. We hypothesized that CL would decrease, and V would increase during CPB compared to pre- or post-CPB states. METHODS: Open-label, single-center, opportunistic pharmacokinetics (PK) and safety study of dexmedetomidine in patients ≤36 months of age administered dexmedetomidine per standard of care via continuous infusion. We analyzed dexmedetomidine PK data using standard nonlinear mixed effects modeling with NONMEM software. We compared model-estimated PK parameters to those from historical patients receiving dexmedetomidine before anesthesia for urologic, lower abdominal, or plastic surgery; after low-risk cardiac or craniofacial surgery; or during bronchoscopy or nuclear magnetic resonance imaging. We investigated the influence of CPB-related factors on PK estimates and used the final model to simulate dosing recommendations, targeting a plasma concentration previously associated with safety and efficacy (0.6 ng/mL). We used the Wilcoxon rank sum test to evaluate differences in dexmedetomidine exposure between infants with hypotension or bradycardia and those who did not develop these adverse events. RESULTS: We collected 213 dexmedetomidine plasma samples from 18 patients. Patients had a median (range) age of 3.3 months (0.1–34.0 months) and underwent CPB for 161 minutes (63–394 minutes). We estimated a CL of 13.4 L/h/70 kg (95% confidence interval, 2.6–24.2 L/h/70 kg) during CPB, compared to 42.1 L/h/70 kg (95% confidence interval, 38.7–45.8 L/h/70 kg) in the historical patients. No specific CPB-related factor had a statistically significant effect on PK. A loading dose of 0.7 µg/kg over 10 minutes before CPB, followed by maintenance infusions through CPB of 0.2 or 0.25 µg/kg/h in infants with postmenstrual ages of 42 or 92 weeks, respectively, maintained targeted concentrations. We identified no association between dexmedetomidine exposure and selected adverse events (P = .13). CONCLUSIONS: CPB is associated with lower CL during CPB in infants and young children compared to those not undergoing CPB. Further study should more closely investigate CPB-related factors that may influence CL.
Anesthesia & Analgesia – Wolters Kluwer Health
Published: Dec 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.